Financhill
Back

Catalent 10K Form

Sell
50

CTLT
Catalent

Last Price:
$63.48
Seasonality Move:
8.65%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive CTLT News And Ratings

See the #1 stock for the next 7 days that we like better than CTLT

CTLT Financial Statistics

Sales & Book Value

Annual Sales: $4.4B
Cash Flow: $4M
Price / Cash Flow: 116.54
Annual Sales: $19.52
Price / Book: 3.25

Profitability

EPS (TTM): -2.27000
Net Income (TTM): $-413M
Gross Margin: $953M
Return on Equity: -11.29%
Return on Assets: -4.18%

Catalent Earnings Forecast

Key Catalent Financial Ratios

  • The Gross Profit Margin over the past 14 years for CTLT is 21.75%.
  • The Selling, General & Administrative Expenses for CTLT have been equal to 21.34% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -24.35% of Operating Income.
  • The Net Earning history of CTLT is -23.81% of Total Revenues.
  • Per Share Earnings over the last 14 years have been positive in 6 years.

Catalent Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: CTLT
CUSIP: 148806
Website: catalent.com

Debt

Debt-to-Equity Ratio: 1.39
Current Ratio: 2.51
Quick Ratio: 1.8

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 36.92

CTLT Technical Analysis vs Fundamental Analysis

Sell
50
Catalent (CTLT) is a Sell

Is Catalent a Buy or a Sell?

  • Catalent stock is rated a Sell
    The current Catalent [CTLT] share price is $63.48. The Score for CTLT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.